Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $19.2000 (-3.52%) ($19.0000 - $20.4000) on Tue. Nov. 28, 2017. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 11.95% (three month average) | RSI | 53 | Latest Price | $19.2000(-3.52%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CAPR declines -2.4% a day on average for past five trading days. | Weekly Trend | CAPR declines -7.1% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) EWG(8%) EWI(8%) SKYY(8%) XLF(8%) ARKK(7%) | Factors Impacting CAPR price | CAPR will decline at least -5.975% in a week (0% probabilities). GLD(-8%) GDX(-8%) TLT(-7%) SLV(-7%) SIL(-6%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -5.975% (StdDev 11.95%) | Hourly BBV | 0 () | Intraday Trend | -4% | | | |
|
1 - 5 Day Possible Target | $3.27(-82.97%) | Resistance Level | $22.46 | 5 Day Moving Average | $20.44(-6.07%) | 10 Day Moving Average | $21.75(-11.72%) | 20 Day Moving Average | $22.46(-14.51%) | To recent high | -44.3% | To recent low | 97.9% | Market Cap | $378m | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |